Summary
The product Nandrolone Phenylpropionate, manufactured by Hilma Biocare, underwent analysis to verify its quality and composition. The sample, procured and funded by RoidTeam.net, a reseller of Hilma Biocare products, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical testing. The analysis confirmed the presence of Nandrolone Phenylpropionate, with a measured concentration of 96.92 mg/ml, slightly below the labeled claim of 100 mg/ml by 3.08%.
The testing process began on 12 June 2023, with the sample received on 20 June 2023, and analysis completed on 23 June 2023. Reseller-funded testing, while informative, may introduce potential biases, as resellers may submit high-quality batches for testing that do not represent the overall consistency of the product. This report is published as part of ongoing harm reduction and consumer education efforts.
Detailed Report
Product Overview
- Manufacturer: Hilma Biocare
- Product Name: Nandrolone Phenylpropionate
- Active Ingredient: Nandrolone Phenylpropionate
- Batch Number: Nandrolone phenylpropionate-062248
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #30522
- Testing Ordered: 12 June 2023
- Sample Received: 20 June 2023
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: RoidTeam.net (Reseller of Hilma Biocare)
- Analysis Paid For By: RoidTeam.net
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 96.92 mg/ml
- Accuracy: 96.92% (3.08% below the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/30522_FQLZRDHWKT6X
- Originally Published: https://thinksteroids.com/community/posts/3221180/
Evaluation of Reseller-Submitted Testing
This analysis demonstrates that the tested product achieves acceptable accuracy but requires careful consideration due to its submission and funding by RoidTeam.net, a reseller of Hilma Biocare products. Reseller-funded testing, similar to manufacturer-funded testing, may introduce potential bias as high-performing batches may be selectively submitted. To ensure reliability and consistency across all market-available batches, independent validation and consumer-submitted testing are recommended. The findings presented here should not be generalized to all products under the same label.
Conclusion
The analysis confirms that Nandrolone Phenylpropionate slightly underdoses its labeled claim, measured at 96.92 mg/ml. While this reflects relatively strong quality control for this batch, it underscores the importance of transparency and independent corroboration. This report supports ongoing harm reduction efforts and provides insights for informed decision-making within the anabolic steroid market.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-funded testing, while informative, may involve inherent biases. The findings pertain solely to the tested batch and do not generalize to all products under the same name. Readers are encouraged to cross-reference these results with independent third-party testing and use this information responsibly.
